7 completed, 1 recruiting, 1 unknown. 9 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 7, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
Follow Tobacco Dependence: new trials by email Literature Review of Tobacco Dependence trials Research Report on Tobacco Dependence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia Nicotine patch, text messaging - Nicotine Dependence, Tobacco Dependence | Phase 1 | Unknown | University of Southern California | 800 | 2023-09-13 | 2023-11-28 |
| Oral Cannabidiol for Tobacco Cessation 300 mg Cannabidiol, 600 mg Cannabidiol, Placebo - Tobacco Use, Tobacco Smoking | Phase 1 | Recruiting | Johns Hopkins University | 50 | 2022-11-01 | 2026-01-07 |
| CO Monitoring for Tobacco Cessation in Quitlines Quitline Treatment as Usual (TAU), Remote Carbon Monoxide (CO) Monitoring, Incentivized Remote CO Monitoring - Tobacco Dependence | Phase 1 / Phase 2 | Completed | Consumer Wellness Solutions | 229 | 2021-12-31 | 2024-10-28 |
| Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy Smokers Nicorette Extra Mint 2 mg Gum, Nicorette Mint 2 mg Gum, Nicorette Extra Mint 4mg Gum - Tobacco Dependence | Phase 1 | Completed | McNeil AB | 76 | 2017-08-14 | 2019-01-03 |
| A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit. Nicorette Strongmint lozenge 4 mg, Niquitin MiniMint lozenge 4 mg - Tobacco Dependence | Phase 1 | Completed | McNeil AB | 244 | 2017-03-20 | 2018-07-27 |
| Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV Web-Based Tailored Smoking Cessation Intervention, Standard of Care - Tobacco Use Cessation, Tobacco Cessation | Phase 1 / Phase 2 | Completed | Georgetown University | 138 | 2011-09-01 | 2014-05-12 |
| Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke Anatabloc(TM), CigRx(R) - Tobacco Use Disorder, Tobacco Dependence | Phase 1 | Completed | Rock Creek Pharmaceuticals, Inc. | 109 | 2011-09-01 | 2015-10-30 |
| Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products Nicotine - Tobacco Dependence | Phase 1 | Completed | McNeil AB | 50 | 2011-02-01 | 2012-07-10 |
| Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers Bupropion SR - Nicotine Dependence, Tobacco Dependence | Phase 1 | Completed | Centre for Addiction and Mental Health | 50 | 2005-06-01 | 2013-02-15 |
Tobacco Use Disorder (9) · Tobacco Use Cessation (3) · Smoking (2) · Acquired Immunodeficiency Syndrome (1) · Smoking Cessation (1) · Tobacco Smoking (1) · Tobacco Use (1)
Chemically-Induced Disorders (9) · Mental Disorders (9) · Substance-Related Disorders (9) · Behavior (5) · Health Behavior (4) · Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · HIV Infections (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1) · Lentivirus Infections (1) · RNA Virus Infections (1) · Retroviridae Infections (1)
Nicotine (2) · Cannabidiol (1) · Chewing Gum (1) · Standard of Care (1) · Tobacco Use Cessation Devices (1)
McNeil AB (3) · Centre for Addiction and Mental Health (1) · Consumer Wellness Solutions (1) · Georgetown University (1) · Johns Hopkins University (1) · Rock Creek Pharmaceuticals, Inc. (1) · University of Southern California (1)
United States (4) · Canada (1) · China (1) · Russia (1) · Sweden (1) · Uganda (1) · Zambia (1)
Dustin C Lee, PhD (1) · Elena P Mazygula, MD (1) · Elisabeth Kruse, PhD (1) · Kelly Carpenter, PhD (1) · Maria Varga, MD (1) · Peter Selby, MD (1) · Shi Aixin, M. Pharm (1)
PMID 12745503, PMID 20124230, PMID 23801018, PMID 25118794, PMID 27215559, PMID 38243301, PMID 40074264, PMID 40684230
R21CA163100 (1), R21DA045744 (1), U01CA261624 (1)